The WHO 45% Modifiable Dementia Risk Estimate in 2026: Practical Evidence-Based Steps for Adults in Midlife

WHO's 2026 guidance ranks which midlife conditions to treat first, and names the supplements it says skip prevention claims entirely.

The World Health Organization now estimates that up to 45% of dementia risk comes from factors people can change, not fixed traits like age or genetics. That figure appears in WHO's updated prevention guidance, released 15–16 July 2026 as the second edition of its "Risk Reduction of Cognitive Decline and Dementia" guidelines, replacing the first edition from 2019. For adults in midlife, the practical message is narrower than the headline number: a specific set of health conditions and habits, measured and managed now, moves the odds. The guidance names the factors, ranks what matters most before versus after midlife, and says plainly what does not help.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

Where the 45% Figure Comes From

The number is not new in 2026 — WHO adopted it from the Lancet Commission's 2024 report, which modeled 14 modifiable risk factors across the life course using population-attributable-fraction calculations built on Norwegian cohort data from the HUNT study, according to the Lancet Commission's 2024 findings. WHO's contribution is turning that modeling into formal clinical guidance for health systems worldwide.

The six factors WHO highlights for its 45% estimate are tobacco use, harmful alcohol use, social isolation, physical inactivity, air pollution exposure, and poorly managed conditions such as hypertension and diabetes, per WHO's July 2026 guidance. These overlap with, but don't fully duplicate, the Lancet Commission's longer 14-factor list, since WHO's guidance emphasizes the factors with the clearest intervention evidence. The stakes behind the estimate are large: an estimated 57 million people live with dementia globally, with close to 10 million new diagnoses each year and a projected rise to 153 million cases by 2050, carrying an annual economic cost of about $1.3 trillion — roughly half of it unpaid family caregiving, according to reporting on the WHO and Lancet Commission data.

Which Risk Factors Matter Most in Midlife

The Lancet Commission's full list splits risk factors by life stage, and midlife carries a distinct cluster. For people roughly in their 40s and 50s, the modifiable factors with the strongest midlife weighting are hearing loss, high LDL cholesterol, depression, traumatic brain injury, physical inactivity, diabetes, smoking, hypertension, obesity, and excessive alcohol use, per the Lancet Commission's 2024 report.

Social isolation, air pollution exposure, and vision loss are classified as later-life factors rather than midlife ones, which matters for sequencing: a 45-year-old's highest-leverage actions are metabolic and cardiovascular, not the social and sensory factors that become more prominent after retirement age. This distinction also explains why WHO's 2026 guidance treats air pollution and multidomain interventions — combining several risk-factor changes at once — as two of its genuine additions over the 2019 edition, according to coverage of the updated guidelines. Midlife adults are better served focusing first on the cardiometabolic factors already on their own list.

What WHO Recommends Doing

WHO's practical recommendations for at-risk and midlife adults center on seven actions: cognitive training and stimulation, increased social engagement, regular physical activity, tobacco cessation, reduced alcohol use, a healthy diet, and effective treatment of hypertension, diabetes, and high cholesterol, per WHO's guidance. For hearing loss specifically, WHO's position is that hearing aids may be offered to people with diagnosed hearing loss as one component of a risk-reduction plan, not a standalone fix, according to the same WHO guidance.

  • Get blood pressure, blood glucose, and cholesterol checked and treated — these three conditions appear repeatedly across both WHO's and the Lancet Commission's lists
  • Stop using tobacco and reduce alcohol intake
  • Build regular physical activity into the week
  • Address hearing loss early; WHO states hearing aids may be offered as part of risk reduction
  • Stay socially and cognitively engaged

What WHO Says Not to Do

WHO explicitly advises against routinely taking vitamin B, vitamin E, omega-3 fatty acid, or multivitamin supplements for dementia prevention, unless a person has a diagnosed deficiency, per WHO's 2026 guidance. This directly rules out a category of products often marketed as brain-health supplements to midlife adults.

The guidance draws a sharp line between supplementation as a general preventive strategy, which it does not support, and treating an actual deficiency, which remains appropriate when diagnosed. Anyone already taking supplements for dementia prevention alone, without a confirmed deficiency, is acting outside what the evidence supports.

The Limits of the 45% Estimate

The "up to 45%" figure is a modeled upper-bound estimate. It assumes the listed risk factors are causal and could be fully eliminated across a population — not that any one individual who addresses all of them is guaranteed a 45% personal risk reduction, according to the Lancet Commission's own framing. The Commission also notes the potential reduction is even larger in low- and middle-income countries, where exposure to several of the risk factors tends to be higher. For a midlife reader, this means the number is best read as a population-level ceiling on preventable cases, not an individual percentage to bank on.

The guidance is still actionable — treating hypertension and quitting smoking have well-established individual benefits regardless of how the population math works out. The Alzheimer's Association has welcomed WHO's updated guidance and is separately developing a U.S.-focused clinical practice guideline on dementia risk reduction, expected in 2027, according to the Alzheimer's Association's statement. That forthcoming guideline may translate WHO's global recommendations into more specific clinical protocols for U.S. primary care settings.

Frequently Asked Questions

Does the 45% figure mean my personal dementia risk drops by 45% if I address every factor?

No. It's a population-level modeled estimate assuming risk factors are fully eliminated across a population, not a guaranteed individual reduction, per the Lancet Commission's 2024 report.

Should I take vitamin E or omega-3 supplements to lower dementia risk?

WHO advises against routinely taking vitamin B, vitamin E, omega-3, or multivitamin supplements for dementia prevention unless a diagnosed deficiency is present.

Is social isolation a midlife risk factor or a later-life one?

The Lancet Commission classifies social isolation, along with air pollution and vision loss, as a later-life factor, while hearing loss, cholesterol, depression, and cardiometabolic conditions carry the midlife weighting.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.